NEW YORK (360Dx) – The French Ministry of Health and Social Affairs on Thursday announced it has approved reimbursement from the country's national health insurance system for a number of tests, including certain genetic tests, as well as interferon-gamma release assays for the screening of tuberculosis.
The ministry originally made its reimbursement decision in late May.
In a document, the ministry said that government insurers will now reimburse for the prenatal determination of fetal RHD genotype from maternal blood in certain instances; diagnosis of enterovirus by gene amplification in cerebrospinal fluid; and detection of C282Y mutation of the HFE1 gene.
The ministry also approved reimbursement for IGRA testing for the screening of TB in certain instances, including for migrant children under the age of 15 from areas with high incidences of TB, and patients with HIV.
According to Qiagen, reimbursement for its IGRA test, the QuantiFeron-TB Gold Plus, will be about €45 ($50) per test.
Oxford Immunotec also offers an IGRA test called the T-Spot.TB test. It said that implementation of new reimbursement codes for IGRA testing is expected in the next 21 days. Its test will be reimbursed at €60 per test.